{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T03:20:12Z","timestamp":1649215212599},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00106-004-1072-6","type":"journal-article","created":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T12:34:59Z","timestamp":1080822899000},"page":"166-173","source":"Crossref","is-referenced-by-count":2,"title":["Dosierung von Botulinumtoxin Typ\ufffdB bei spasmodischer Dysphonie vom Adduktortyp"],"prefix":"10.1007","volume":"53","author":[{"given":"R.","family":"Sch\ufffdnweiler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zwirner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","unstructured":"Aronson AE (1985) Clinical voice disorders. Thieme, New York"},{"key":"CR2","unstructured":"Binschek T, Wellh\u00f6ner HH (1999) Struktur und Wirkungsmechanismus der Botulinum-Neurotoxine. In: Laskawi R, Roggenk\u00e4mper P (Hrsg) Botulinum-Toxine im Kopf-Hals-Bereich. Urban & Vogel, M\u00fcnchen, S\u00a012?36"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/000348949110000201","volume":"100","author":"Blitzer","year":"1991","unstructured":"Blitzer A, Brin MF (1991) Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 100: 85?89","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","volume":"53","author":"Brin","year":"1999","unstructured":"Brin MF, Lew MF, Adler CH et al. (1999) Safetey and efficiacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53: 1431?1438","journal-title":"Neurology"},{"key":"CR5","first-page":"240","volume":"Neurophysiol","author":"Dressler","year":"2001","unstructured":"Dressler D, Benecke R (2001) Botulinumtoxin Typ\u00a0B: M\u00f6glichkeiten und Grenzen der klinischen Anwendungen. Klin Neurophysiol: 240?243","journal-title":"Klin"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00115-001-1239-2","volume":"73","author":"Dressler","year":"2002","unstructured":"Dressler D, Benecke R (2002) Erste Erfahrungen mit der klinischen Anwendung von Botulinum-Toxin Typ\u00a0B. Nervenarzt 73: 194?198","journal-title":"Nervenarzt"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s004150050230","volume":"35","author":"Dressler","year":"1998","unstructured":"Dressler D, Rothwell.JC, Marsden CD (1998) Comparing biological potencies of Botox and Dysport with a mouse diaphragm model may mislead. J Neurol 35: 332","journal-title":"J Neurol"},{"key":"CR8","unstructured":"Fahn S (1994) Dystonia. In: Jankovic J, Hallett M (eds) Therapy with botulinum toxin. Dekker, New York, pp\u00a0173?189"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005537-200304000-00029","volume":"113","author":"Guntinas-Lichius","year":"2003","unstructured":"Guntinas-Lichius O (2003) Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A. Laryngoscope 113: 743?745","journal-title":"Laryngoscope"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2008-1061837","volume":"8","author":"Gutenbrunner","year":"1998","unstructured":"Gutenbrunner C, Ptok M, Gehrke A (1998) Stimmheilintensivtherapie?Aspekte der Physikalischen Medizin. Phys Rehab Kur Med 8: 128?134","journal-title":"Phys Rehab Kur Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1055\/s-2002-34999","volume":"81","author":"Kiese-Himmel","year":"2002","unstructured":"Kiese-Himmel C, Reeh M, Liebeck H, Zwirner P (2002) Ver\u00e4ndern sich psychologische Faktoren bei Patienten mit spasmodischer Dysphonie nach Botulinum-Toxin-Injektion? Laryngorhinootologie 81: 683?689","journal-title":"Laryngorhinootologie"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s001060050240","volume":"46","author":"Laskawi","year":"1998","unstructured":"Laskawi R (1998) Die therapeutische Anwendung von Botulinum-Toxin im Hals-Nasen-Ohren-Bereich. Teil 1: Die Behandlung von Bewegungsst\u00f6rungen der mimischen Muskulatur. HNO 46: 281?287","journal-title":"HNO"},{"key":"CR13","unstructured":"Lew MF, Braschear A, Factor S (2000) The safety and efficiacy of botulinum toxin type B in the treatment of patient with cervical dystonia: summary of three controlled clinical trials. Neurology 55 (Suppl\u00a05): 29?35"},{"key":"CR14","doi-asserted-by":"crossref","unstructured":"Luchsinger R, Arnold E (1970) Handbuch der Stimm- und Sprachheilkunde: Die Stimme und ihre St\u00f6rungen, 3.\u00a0Aufl, Bd\u00a01. Springer, Wien New York","DOI":"10.1007\/978-3-7091-7128-8_1"},{"key":"CR15","unstructured":"Naumann M (1998) Botulinumtoxin?Grundlagen. In: Naumann M (Hrsg) Botulinumtoxin?Wirkprinzip und klinische Anwendung, 1.\u00a0Aufl. UNI-MED, Bremen, S\u00a012?18"},{"key":"CR16","unstructured":"Nawka T, Anders LC, Wendler J (1994) Die auditive Beurteilung heiserer Stimmen nach dem RBH-System. Sprache Stimme Geh\u00f6r 18: 130?133"},{"key":"CR17","unstructured":"Pototschnig C, Thumfart WF (1999) Die Behandlung der spasmodischen Dysphonie. In: Laskawi R, Roggenk\u00e4mper P (Hrsg) Botulinum-Toxin-Therapie im Kopf-Hals-Bereich. Urban & Vogel, M\u00fcnchen, S\u00a0135?151"},{"key":"CR18","first-page":"293","volume":"50","author":"Raes","year":"1996","unstructured":"Raes JPF, Clement PAR (1996) Aerodynamic measurements of voice production. Acta Otorhinolaryngol Belg 50: 293?298","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"6","author":"Sampaio","year":"1997","unstructured":"Sampaio C, Ferreira JJ, Simoes F et al. (1997) DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficiacy and tolerability of two formulations of botulinum toxin type A?Dysport and Botox?assuming a ratio of 4: 1. Mov Disord 6: 1013?1018","journal-title":"Mov Disord"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0892-1997(02)00114-5","volume":"16","author":"Sataloff","year":"2002","unstructured":"Sataloff RT, Heman-Ackah YD, Simpson LL, Park J-B, Zwislewski A, Sokolow C, Mandel S (2002) Botulinum toxin type B for treatment of spasmodic dysphonia. J Voice 16: 422?424","journal-title":"J Voice"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005537-199801000-00011","volume":"108","author":"Sch\u00f6nweiler","year":"1998","unstructured":"Sch\u00f6nweiler R, Wohlfarth K, Dengler R, Ptok M (1998) Supraglottal injection of Botulinum Toxin A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction. Laryngoscope 108: 55?63","journal-title":"Laryngoscope"},{"key":"CR22","unstructured":"Schultz-Coulon HJ, Klingholz F (1988) Objektive und semiobjektive Untersuchungsmethoden der Stimme. In: Kittel G, Sch\u00fcrenberg B (Hrsg) Objektive und semiobjektive Untersuchungsm\u00f6glichkeiten von Stimme, Sprache und Geh\u00f6r. Dtsch \u00c4rzte-Verlag, K\u00f6ln. S\u00a01?71"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","volume":"49","author":"Sloop","year":"1997","unstructured":"Sloop RR, Cole BA, Escutin RO (1997) Human response to botulinum toxin injection: type B compared to type A. Neurology 49: 189?194","journal-title":"Neurology"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1212\/WNL.45.11.2109","volume":"45","author":"Tsui","year":"1995","unstructured":"Tsui JKC, Hayward M, Mak EKM, Schulzer M (1995) Botulinum toxin type B in the treatment of cervical dystonia: a pilot study. Neurology 45: 2109?2110","journal-title":"Neurology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00004951","volume":"355","author":"Wohlfarth","year":"1997","unstructured":"Wohlfarth K, G\u00f6schel H, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxins: units vs. units. Naunyn Schmiedebergs Arch Pharmacol 355: 335?340","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s001060050047","volume":"44","author":"Zwirner","year":"1996","unstructured":"Zwirner P, Michaelis D, Kruse E (1996) Akustische Stimmanalysen zur Dokumentation der Stimmrehabilitation nach laserchirurgischer Larynxkarzinomresektion. HNO 44: 514?520","journal-title":"HNO"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1288\/00005537-199204000-00006","volume":"102","author":"Zwirner","year":"1992","unstructured":"Zwirner P, Murry T, Swenson M, Woodson GE (1992) Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings. Laryngoscope 102: 400?406","journal-title":"Laryngoscope"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00186224","volume":"250","author":"Zwirner","year":"1993","unstructured":"Zwirner P, Murry T, Woodson GE (1993) A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia. Eur Arch Otorhinolaryngol 250: 271?276","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-004-1072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-004-1072-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-004-1072-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T21:23:14Z","timestamp":1585689794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-004-1072-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1007\/s00106-004-1072-6","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}